APO Research

APO RESEARCH · REPORT

Sacubitril Valsartan Sodium Tablets

Selected research

Market Outlook & Growth Opportunities

Global Sacubitril Valsartan Sodium Tablets Market Outlook and Growth Opportunities 2026

Market perspective

The global Sacubitril Valsartan Sodium Tablets market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Sacubitril Valsartan Sodium Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Sacubitril Valsartan Sodium Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Sacubitril Valsartan Sodium Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Sacubitril Valsartan Sodium Tablets market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Sacubitril Valsartan Sodium Tablets market include Addii Biotech, Arlak Corazon, Cipla, Farmanova pharma, General Pharmaceuticals, MSN, Novartis, Sanof and Changzhou Pharmaceutical Factory, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Sacubitril Valsartan Sodium Tablets market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Sacubitril Valsartan Sodium Tablets and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Sacubitril Valsartan Sodium Tablets sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Sacubitril Valsartan Sodium Tablets market size, projected growth trends, production technologies, key applications, and end-use industries.

Sacubitril Valsartan Sodium Tablets Segment by Company

Addii Biotech

Arlak Corazon

Cipla

Farmanova pharma

General Pharmaceuticals

MSN

Novartis

Sanof

Changzhou Pharmaceutical Factory

Chengdu Brilliant Pharmaceutical

TC Pharmaceuticals (Jiangsu)

Sino Therapeutics

Kelun Pharmaceutical

Qilu Pharmaceutical

Shenzhen Salubris Pharmaceuticals

CSPC Ouyi Pharmaceutical

Sihuan Pharmaceutical

Zhejiang AngLiKang Pharmaceutical

Zhejiang Nord Pharmaceutical

Chia Tai Tianqing Pharmaceutical

Sacubitril Valsartan Sodium Tablets Segment by Type

50mg per Tablet

100mg per Tablet

200mg per Tablet

Sacubitril Valsartan Sodium Tablets Segment by Application

Hospital and Clinic

Retail Pharmacies

Other

Sacubitril Valsartan Sodium Tablets Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Sacubitril Valsartan Sodium Tablets status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Sacubitril Valsartan Sodium Tablets market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Sacubitril Valsartan Sodium Tablets significant trends, drivers, influence factors in global and regions.

6. To analyze Sacubitril Valsartan Sodium Tablets competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Sacubitril Valsartan Sodium Tablets market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Sacubitril Valsartan Sodium Tablets and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Sacubitril Valsartan Sodium Tablets.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Sacubitril Valsartan Sodium Tablets market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Sacubitril Valsartan Sodium Tablets industry.

Chapter 3: Detailed analysis of Sacubitril Valsartan Sodium Tablets manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Sacubitril Valsartan Sodium Tablets in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Sacubitril Valsartan Sodium Tablets in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Sacubitril Valsartan Sodium Tablets Industry Trends Table 2. Sacubitril Valsartan Sodium Tablets Industry Drivers Table 3. Sacubitril Valsartan Sodium Tablets Industry Opportunities and Challenges Table 4. Sacubitril Valsartan Sodium Tablets Industry Restraints Table 5. Global Sacubitril Valsartan Sodium Tablets Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Sacubitril Valsartan Sodium Tablets Revenue Share by Company (2021-2026) Table 7. Global Sacubitril Valsartan Sodium Tablets Sales Volume by Company (K Units) & (2021-2026) Table 8. Global Sacubitril Valsartan Sodium Tablets Sales Volume Share by Company (2021-2026) Table 9. Global Sacubitril Valsartan Sodium Tablets Average Price (US$/Unit) of Company (2021-2026) Table 10. Global Sacubitril Valsartan Sodium Tablets Company Ranking, (2024-2026) & (USD Million) Table 11. Global Sacubitril Valsartan Sodium Tablets Key Company Manufacturing Base & Headquarters Table 12. Global Sacubitril Valsartan Sodium Tablets Company, Product Type & Application Table 13. Global Sacubitril Valsartan Sodium Tablets Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Sacubitril Valsartan Sodium Tablets by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of 50mg per Tablet Table 18. Significant Companies of 100mg per Tablet Table 19. Significant Companies of 200mg per Tablet Table 20. Global Sacubitril Valsartan Sodium Tablets Sales Volume by Type 2021 VS 2025 VS 2032 (K Units) Table 21. Global Sacubitril Valsartan Sodium Tablets Sales Volume by Type (2021-2026) & (K Units) Table 22. Global Sacubitril Valsartan Sodium Tablets Sales Volume by Type (2027-2032) & (K Units) Table 23. Global Sacubitril Valsartan Sodium Tablets Sales Volume Share by Type (2021-2026) Table 24. Global Sacubitril Valsartan Sodium Tablets Sales Volume Share by Type (2027-2032) Table 25. Global Sacubitril Valsartan Sodium Tablets Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Sacubitril Valsartan Sodium Tablets Sales Value by Type (2021-2026) & (US$ Million) Table 27. Global Sacubitril Valsartan Sodium Tablets Sales Value by Type (2027-2032) & (US$ Million) Table 28. Global Sacubitril Valsartan Sodium Tablets Sales Value Share by Type (2021-2026) Table 29. Global Sacubitril Valsartan Sodium Tablets Sales Value Share by Type (2027-2032) Table 30. Significant Companies of Hospital and Clinic Table 31. Significant Companies of Retail Pharmacies Table 32. Significant Companies of Other Table 33. Global Sacubitril Valsartan Sodium Tablets Sales Volume by Application 2021 VS 2025 VS 2032 (K Units) Table 34. Global Sacubitril Valsartan Sodium Tablets Sales Volume by Application (2021-2026) & (K Units) Table 35. Global Sacubitril Valsartan Sodium Tablets Sales Volume by Application (2027-2032) & (K Units) Table 36. Global Sacubitril Valsartan Sodium Tablets Sales Volume Share by Application (2021-2026) Table 37. Global Sacubitril Valsartan Sodium Tablets Sales Volume Share by Application (2027-2032) Table 38. Global Sacubitril Valsartan Sodium Tablets Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 39. Global Sacubitril Valsartan Sodium Tablets Sales Value by Application (2021-2026) & (US$ Million) Table 40. Global Sacubitril Valsartan Sodium Tablets Sales Value by Application (2027-2032) & (US$ Million) Table 41. Global Sacubitril Valsartan Sodium Tablets Sales Value Share by Application (2021-2026) Table 42. Global Sacubitril Valsartan Sodium Tablets Sales Value Share by Application (2027-2032) Table 43. Global Sacubitril Valsartan Sodium Tablets Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 44. Global Sacubitril Valsartan Sodium Tablets Sales by Region (2021-2026) & (K Units) Table 45. Global Sacubitril Valsartan Sodium Tablets Sales Market Share by Region (2021-2026) Table 46. Global Sacubitril Valsartan Sodium Tablets Sales by Region (2027-2032) & (K Units) Table 47. Global Sacubitril Valsartan Sodium Tablets Sales Market Share by Region (2027-2032) Table 48. Global Sacubitril Valsartan Sodium Tablets Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 49. Global Sacubitril Valsartan Sodium Tablets Sales Value by Region (2021-2026) & (US$ Million) Table 50. Global Sacubitril Valsartan Sodium Tablets Sales Value Share by Region (2021-2026) Table 51. Global Sacubitril Valsartan Sodium Tablets Sales Value by Region (2027-2032) & (US$ Million) Table 52. Global Sacubitril Valsartan Sodium Tablets Sales Value Share by Region (2027-2032) Table 53. Global Sacubitril Valsartan Sodium Tablets Market Average Price (US$/Unit) by Region (2021-2026) Table 54. Global Sacubitril Valsartan Sodium Tablets Market Average Price (US$/Unit) by Region (2027-2032) Table 55. Global Sacubitril Valsartan Sodium Tablets Sales by Country: 2021 VS 2025 VS 2032 (K Units) Table 56. Global Sacubitril Valsartan Sodium Tablets Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 57. Global Sacubitril Valsartan Sodium Tablets Sales by Country (2021-2026) & (K Units) Table 58. Global Sacubitril Valsartan Sodium Tablets Sales Market Share by Country (2021-2026) Table 59. Global Sacubitril Valsartan Sodium Tablets Sales by Country (2027-2032) & (K Units) Table 60. Global Sacubitril Valsartan Sodium Tablets Sales Market Share by Country (2027-2032) Table 61. Global Sacubitril Valsartan Sodium Tablets Sales Value by Country (2021-2026) & (US$ Million) Table 62. Global Sacubitril Valsartan Sodium Tablets Sales Value Market Share by Country (2021-2026) Table 63. Global Sacubitril Valsartan Sodium Tablets Sales Value by Country (2027-2032) & (US$ Million) Table 64. Global Sacubitril Valsartan Sodium Tablets Sales Value Market Share by Country (2027-2032) Table 65. Addii Biotech Company Information Table 66. Addii Biotech Business Overview Table 67. Addii Biotech Sacubitril Valsartan Sodium Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 68. Addii Biotech Sacubitril Valsartan Sodium Tablets Product Portfolio Table 69. Addii Biotech Recent Development Table 70. Arlak Corazon Company Information Table 71. Arlak Corazon Business Overview Table 72. Arlak Corazon Sacubitril Valsartan Sodium Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 73. Arlak Corazon Sacubitril Valsartan Sodium Tablets Product Portfolio Table 74. Arlak Corazon Recent Development Table 75. Cipla Company Information Table 76. Cipla Business Overview Table 77. Cipla Sacubitril Valsartan Sodium Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 78. Cipla Sacubitril Valsartan Sodium Tablets Product Portfolio Table 79. Cipla Recent Development Table 80. Farmanova pharma Company Information Table 81. Farmanova pharma Business Overview Table 82. Farmanova pharma Sacubitril Valsartan Sodium Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 83. Farmanova pharma Sacubitril Valsartan Sodium Tablets Product Portfolio Table 84. Farmanova pharma Recent Development Table 85. General Pharmaceuticals Company Information Table 86. General Pharmaceuticals Business Overview Table 87. General Pharmaceuticals Sacubitril Valsartan Sodium Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 88. General Pharmaceuticals Sacubitril Valsartan Sodium Tablets Product Portfolio Table 89. General Pharmaceuticals Recent Development Table 90. MSN Company Information Table 91. MSN Business Overview Table 92. MSN Sacubitril Valsartan Sodium Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 93. MSN Sacubitril Valsartan Sodium Tablets Product Portfolio Table 94. MSN Recent Development Table 95. Novartis Company Information Table 96. Novartis Business Overview Table 97. Novartis Sacubitril Valsartan Sodium Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 98. Novartis Sacubitril Valsartan Sodium Tablets Product Portfolio Table 99. Novartis Recent Development Table 100. Sanof Company Information Table 101. Sanof Business Overview Table 102. Sanof Sacubitril Valsartan Sodium Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 103. Sanof Sacubitril Valsartan Sodium Tablets Product Portfolio Table 104. Sanof Recent Development Table 105. Changzhou Pharmaceutical Factory Company Information Table 106. Changzhou Pharmaceutical Factory Business Overview Table 107. Changzhou Pharmaceutical Factory Sacubitril Valsartan Sodium Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 108. Changzhou Pharmaceutical Factory Sacubitril Valsartan Sodium Tablets Product Portfolio Table 109. Changzhou Pharmaceutical Factory Recent Development Table 110. Chengdu Brilliant Pharmaceutical Company Information Table 111. Chengdu Brilliant Pharmaceutical Business Overview Table 112. Chengdu Brilliant Pharmaceutical Sacubitril Valsartan Sodium Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 113. Chengdu Brilliant Pharmaceutical Sacubitril Valsartan Sodium Tablets Product Portfolio Table 114. Chengdu Brilliant Pharmaceutical Recent Development Table 115. TC Pharmaceuticals (Jiangsu) Company Information Table 116. TC Pharmaceuticals (Jiangsu) Business Overview Table 117. TC Pharmaceuticals (Jiangsu) Sacubitril Valsartan Sodium Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 118. TC Pharmaceuticals (Jiangsu) Sacubitril Valsartan Sodium Tablets Product Portfolio Table 119. TC Pharmaceuticals (Jiangsu) Recent Development Table 120. Sino Therapeutics Company Information Table 121. Sino Therapeutics Business Overview Table 122. Sino Therapeutics Sacubitril Valsartan Sodium Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 123. Sino Therapeutics Sacubitril Valsartan Sodium Tablets Product Portfolio Table 124. Sino Therapeutics Recent Development Table 125. Kelun Pharmaceutical Company Information Table 126. Kelun Pharmaceutical Business Overview Table 127. Kelun Pharmaceutical Sacubitril Valsartan Sodium Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 128. Kelun Pharmaceutical Sacubitril Valsartan Sodium Tablets Product Portfolio Table 129. Kelun Pharmaceutical Recent Development Table 130. Qilu Pharmaceutical Company Information Table 131. Qilu Pharmaceutical Business Overview Table 132. Qilu Pharmaceutical Sacubitril Valsartan Sodium Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 133. Qilu Pharmaceutical Sacubitril Valsartan Sodium Tablets Product Portfolio Table 134. Qilu Pharmaceutical Recent Development Table 135. Shenzhen Salubris Pharmaceuticals Company Information Table 136. Shenzhen Salubris Pharmaceuticals Business Overview Table 137. Shenzhen Salubris Pharmaceuticals Sacubitril Valsartan Sodium Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 138. Shenzhen Salubris Pharmaceuticals Sacubitril Valsartan Sodium Tablets Product Portfolio Table 139. Shenzhen Salubris Pharmaceuticals Recent Development Table 140. CSPC Ouyi Pharmaceutical Company Information Table 141. CSPC Ouyi Pharmaceutical Business Overview Table 142. CSPC Ouyi Pharmaceutical Sacubitril Valsartan Sodium Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 143. CSPC Ouyi Pharmaceutical Sacubitril Valsartan Sodium Tablets Product Portfolio Table 144. CSPC Ouyi Pharmaceutical Recent Development Table 145. Sihuan Pharmaceutical Company Information Table 146. Sihuan Pharmaceutical Business Overview Table 147. Sihuan Pharmaceutical Sacubitril Valsartan Sodium Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 148. Sihuan Pharmaceutical Sacubitril Valsartan Sodium Tablets Product Portfolio Table 149. Sihuan Pharmaceutical Recent Development Table 150. Zhejiang AngLiKang Pharmaceutical Company Information Table 151. Zhejiang AngLiKang Pharmaceutical Business Overview Table 152. Zhejiang AngLiKang Pharmaceutical Sacubitril Valsartan Sodium Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 153. Zhejiang AngLiKang Pharmaceutical Sacubitril Valsartan Sodium Tablets Product Portfolio Table 154. Zhejiang AngLiKang Pharmaceutical Recent Development Table 155. Zhejiang Nord Pharmaceutical Company Information Table 156. Zhejiang Nord Pharmaceutical Business Overview Table 157. Zhejiang Nord Pharmaceutical Sacubitril Valsartan Sodium Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 158. Zhejiang Nord Pharmaceutical Sacubitril Valsartan Sodium Tablets Product Portfolio Table 159. Zhejiang Nord Pharmaceutical Recent Development Table 160. Chia Tai Tianqing Pharmaceutical Company Information Table 161. Chia Tai Tianqing Pharmaceutical Business Overview Table 162. Chia Tai Tianqing Pharmaceutical Sacubitril Valsartan Sodium Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 163. Chia Tai Tianqing Pharmaceutical Sacubitril Valsartan Sodium Tablets Product Portfolio Table 164. Chia Tai Tianqing Pharmaceutical Recent Development Table 165. Key Raw Materials Table 166. Raw Materials Key Suppliers Table 167. Sacubitril Valsartan Sodium Tablets Distributors List Table 168. Sacubitril Valsartan Sodium Tablets Customers List Table 169. Research Programs/Design for This Report Table 170. Authors List of This Report Table 171. Secondary Sources Table 172. Primary Sources List of Figures Figure 1. Sacubitril Valsartan Sodium Tablets Product Image Figure 2. Global Sacubitril Valsartan Sodium Tablets Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Sacubitril Valsartan Sodium Tablets Sales Value (2021-2032) & (US$ Million) Figure 4. Global Sacubitril Valsartan Sodium Tablets Sales (2021-2032) & (K Units) Figure 5. Global Sacubitril Valsartan Sodium Tablets Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global Sacubitril Valsartan Sodium Tablets Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. 50mg per Tablet Image Figure 10. 100mg per Tablet Image Figure 11. 200mg per Tablet Image Figure 12. Global Sacubitril Valsartan Sodium Tablets Sales Volume by Type (2021 VS 2025 VS 2032) & (K Units) Figure 13. Global Sacubitril Valsartan Sodium Tablets Sales Volume Share 2021 VS 2025 VS 2032 Figure 14. Global Sacubitril Valsartan Sodium Tablets Sales Volume Share by Type (2021-2032) Figure 15. Global Sacubitril Valsartan Sodium Tablets Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Sacubitril Valsartan Sodium Tablets Sales Value Share 2021 VS 2025 VS 2032 Figure 17. Global Sacubitril Valsartan Sodium Tablets Sales Value Share by Type (2021-2032) Figure 18. Hospital and Clinic Image Figure 19. Retail Pharmacies Image Figure 20. Other Image Figure 21. Global Sacubitril Valsartan Sodium Tablets Sales Volume by Application (2021 VS 2025 VS 2032) & (K Units) Figure 22. Global Sacubitril Valsartan Sodium Tablets Sales Volume Share 2021 VS 2025 VS 2032 Figure 23. Global Sacubitril Valsartan Sodium Tablets Sales Volume Share by Application (2021-2032) Figure 24. Global Sacubitril Valsartan Sodium Tablets Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 25. Global Sacubitril Valsartan Sodium Tablets Sales Value Share 2021 VS 2025 VS 2032 Figure 26. Global Sacubitril Valsartan Sodium Tablets Sales Value Share by Application (2021-2032) Figure 27. Global Sacubitril Valsartan Sodium Tablets Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 28. Global Sacubitril Valsartan Sodium Tablets Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 29. Global Sacubitril Valsartan Sodium Tablets Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 30. Global Sacubitril Valsartan Sodium Tablets Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 31. North America Sacubitril Valsartan Sodium Tablets Sales Value (2021-2032) & (US$ Million) Figure 32. North America Sacubitril Valsartan Sodium Tablets Sales Value Share by Country (%), 2025 VS 2032 Figure 33. Europe Sacubitril Valsartan Sodium Tablets Sales Value (2021-2032) & (US$ Million) Figure 34. Europe Sacubitril Valsartan Sodium Tablets Sales Value Share by Country (%), 2025 VS 2032 Figure 35. Asia-Pacific Sacubitril Valsartan Sodium Tablets Sales Value (2021-2032) & (US$ Million) Figure 36. Asia-Pacific Sacubitril Valsartan Sodium Tablets Sales Value Share by Country (%), 2025 VS 2032 Figure 37. South America Sacubitril Valsartan Sodium Tablets Sales Value (2021-2032) & (US$ Million) Figure 38. South America Sacubitril Valsartan Sodium Tablets Sales Value Share by Country (%), 2025 VS 2032 Figure 39. Middle East & Africa Sacubitril Valsartan Sodium Tablets Sales Value (2021-2032) & (US$ Million) Figure 40. Middle East & Africa Sacubitril Valsartan Sodium Tablets Sales Value Share by Country (%), 2025 VS 2032 Figure 41. USA Sacubitril Valsartan Sodium Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. USA Sacubitril Valsartan Sodium Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. USA Sacubitril Valsartan Sodium Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. Canada Sacubitril Valsartan Sodium Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. Canada Sacubitril Valsartan Sodium Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. Canada Sacubitril Valsartan Sodium Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. Mexico Sacubitril Valsartan Sodium Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. Mexico Sacubitril Valsartan Sodium Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. Mexico Sacubitril Valsartan Sodium Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Germany Sacubitril Valsartan Sodium Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Germany Sacubitril Valsartan Sodium Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Germany Sacubitril Valsartan Sodium Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. France Sacubitril Valsartan Sodium Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. France Sacubitril Valsartan Sodium Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. France Sacubitril Valsartan Sodium Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. U.K. Sacubitril Valsartan Sodium Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. U.K. Sacubitril Valsartan Sodium Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. U.K. Sacubitril Valsartan Sodium Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Italy Sacubitril Valsartan Sodium Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Italy Sacubitril Valsartan Sodium Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Italy Sacubitril Valsartan Sodium Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Spain Sacubitril Valsartan Sodium Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Spain Sacubitril Valsartan Sodium Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Spain Sacubitril Valsartan Sodium Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. Russia Sacubitril Valsartan Sodium Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. Russia Sacubitril Valsartan Sodium Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. Russia Sacubitril Valsartan Sodium Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Netherlands Sacubitril Valsartan Sodium Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Netherlands Sacubitril Valsartan Sodium Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Netherlands Sacubitril Valsartan Sodium Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. Nordic Countries Sacubitril Valsartan Sodium Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. Nordic Countries Sacubitril Valsartan Sodium Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. Nordic Countries Sacubitril Valsartan Sodium Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. China Sacubitril Valsartan Sodium Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. China Sacubitril Valsartan Sodium Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. China Sacubitril Valsartan Sodium Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Japan Sacubitril Valsartan Sodium Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Japan Sacubitril Valsartan Sodium Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Japan Sacubitril Valsartan Sodium Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. South Korea Sacubitril Valsartan Sodium Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. South Korea Sacubitril Valsartan Sodium Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. South Korea Sacubitril Valsartan Sodium Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. India Sacubitril Valsartan Sodium Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. India Sacubitril Valsartan Sodium Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. India Sacubitril Valsartan Sodium Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Australia Sacubitril Valsartan Sodium Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Australia Sacubitril Valsartan Sodium Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Australia Sacubitril Valsartan Sodium Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Southeast Asia Sacubitril Valsartan Sodium Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Southeast Asia Sacubitril Valsartan Sodium Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Southeast Asia Sacubitril Valsartan Sodium Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Brazil Sacubitril Valsartan Sodium Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Brazil Sacubitril Valsartan Sodium Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Brazil Sacubitril Valsartan Sodium Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Argentina Sacubitril Valsartan Sodium Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Argentina Sacubitril Valsartan Sodium Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Argentina Sacubitril Valsartan Sodium Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Chile Sacubitril Valsartan Sodium Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Chile Sacubitril Valsartan Sodium Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Chile Sacubitril Valsartan Sodium Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Colombia Sacubitril Valsartan Sodium Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Colombia Sacubitril Valsartan Sodium Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Colombia Sacubitril Valsartan Sodium Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. Peru Sacubitril Valsartan Sodium Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. Peru Sacubitril Valsartan Sodium Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. Peru Sacubitril Valsartan Sodium Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Saudi Arabia Sacubitril Valsartan Sodium Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Saudi Arabia Sacubitril Valsartan Sodium Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Saudi Arabia Sacubitril Valsartan Sodium Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Israel Sacubitril Valsartan Sodium Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Israel Arabia Sacubitril Valsartan Sodium Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Israel Arabia Sacubitril Valsartan Sodium Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. UAE Sacubitril Valsartan Sodium Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. UAE Sacubitril Valsartan Sodium Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. UAE Sacubitril Valsartan Sodium Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Turkey Sacubitril Valsartan Sodium Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 117. Turkey Sacubitril Valsartan Sodium Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 118. Turkey Sacubitril Valsartan Sodium Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 119. Iran Sacubitril Valsartan Sodium Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 120. Iran Sacubitril Valsartan Sodium Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 121. Iran Sacubitril Valsartan Sodium Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 122. Egypt Sacubitril Valsartan Sodium Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 123. Egypt Sacubitril Valsartan Sodium Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 124. Egypt Sacubitril Valsartan Sodium Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 125. Sacubitril Valsartan Sodium Tablets Value Chain Figure 126. Manufacturing Cost Structure Figure 127. Sacubitril Valsartan Sodium Tablets Sales Mode & Process Figure 128. Direct Comparison with Distribution Share Figure 129. Distributors Profiles Figure 130. Years Considered Figure 131. Research Process Figure 132. Key Executives Interviewed

Scope & coverage.

Types
  • 50mg per Tablet
  • 100mg per Tablet
  • 200mg per Tablet
Applications
  • Hospital and Clinic
  • Retail Pharmacies
  • Other
Companies covered
  • Addii Biotech
  • Arlak Corazon
  • Cipla
  • Farmanova pharma
  • General Pharmaceuticals
  • MSN
  • Novartis
  • Sanof
  • Changzhou Pharmaceutical Factory
  • Chengdu Brilliant Pharmaceutical
  • TC Pharmaceuticals (Jiangsu)
  • Sino Therapeutics
  • Kelun Pharmaceutical
  • Qilu Pharmaceutical
  • Shenzhen Salubris Pharmaceuticals
  • CSPC Ouyi Pharmaceutical
  • Sihuan Pharmaceutical
  • Zhejiang AngLiKang Pharmaceutical
  • Zhejiang Nord Pharmaceutical
  • Chia Tai Tianqing Pharmaceutical

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Sacubitril Valsartan Sodium Tablets Sales Value (2021-2032)
  4. 1.2.2 Global Sacubitril Valsartan Sodium Tablets Sales Volume (2021-2032)
  5. 1.2.3 Global Sacubitril Valsartan Sodium Tablets Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Sacubitril Valsartan Sodium Tablets Market Dynamics
  1. 2.1 Sacubitril Valsartan Sodium Tablets Industry Trends
  2. 2.2 Sacubitril Valsartan Sodium Tablets Industry Drivers
  3. 2.3 Sacubitril Valsartan Sodium Tablets Industry Opportunities and Challenges
  4. 2.4 Sacubitril Valsartan Sodium Tablets Industry Restraints
3 Sacubitril Valsartan Sodium Tablets Market by Company
  1. 3.1 Global Sacubitril Valsartan Sodium Tablets Company Revenue Ranking in 2025
  2. 3.2 Global Sacubitril Valsartan Sodium Tablets Revenue by Company (2021-2026)
  3. 3.3 Global Sacubitril Valsartan Sodium Tablets Sales Volume by Company (2021-2026)
  4. 3.4 Global Sacubitril Valsartan Sodium Tablets Average Price by Company (2021-2026)
  5. 3.5 Global Sacubitril Valsartan Sodium Tablets Company Ranking (2024-2026)
  6. 3.6 Global Sacubitril Valsartan Sodium Tablets Company Manufacturing Base and Headquarters
  7. 3.7 Global Sacubitril Valsartan Sodium Tablets Company Product Type and Application
  8. 3.8 Global Sacubitril Valsartan Sodium Tablets Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Sacubitril Valsartan Sodium Tablets Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Sacubitril Valsartan Sodium Tablets Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Sacubitril Valsartan Sodium Tablets Market by Type
  1. 4.1 Sacubitril Valsartan Sodium Tablets Type Introduction
  2. 4.1.1 50mg per Tablet
  3. 4.1.2 100mg per Tablet
  4. 4.1.3 200mg per Tablet
  5. 4.2 Global Sacubitril Valsartan Sodium Tablets Sales Volume by Type
  6. 4.2.1 Global Sacubitril Valsartan Sodium Tablets Sales Volume by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Sacubitril Valsartan Sodium Tablets Sales Volume by Type (2021-2032)
  8. 4.2.3 Global Sacubitril Valsartan Sodium Tablets Sales Volume Share by Type (2021-2032)
  9. 4.3 Global Sacubitril Valsartan Sodium Tablets Sales Value by Type
  10. 4.3.1 Global Sacubitril Valsartan Sodium Tablets Sales Value by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Sacubitril Valsartan Sodium Tablets Sales Value by Type (2021-2032)
  12. 4.3.3 Global Sacubitril Valsartan Sodium Tablets Sales Value Share by Type (2021-2032)
5 Sacubitril Valsartan Sodium Tablets Market by Application
  1. 5.1 Sacubitril Valsartan Sodium Tablets Application Introduction
  2. 5.1.1 Hospital and Clinic
  3. 5.1.2 Retail Pharmacies
  4. 5.1.3 Other
  5. 5.2 Global Sacubitril Valsartan Sodium Tablets Sales Volume by Application
  6. 5.2.1 Global Sacubitril Valsartan Sodium Tablets Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Sacubitril Valsartan Sodium Tablets Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Sacubitril Valsartan Sodium Tablets Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Sacubitril Valsartan Sodium Tablets Sales Value by Application
  10. 5.3.1 Global Sacubitril Valsartan Sodium Tablets Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Sacubitril Valsartan Sodium Tablets Sales Value by Application (2021-2032)
  12. 5.3.3 Global Sacubitril Valsartan Sodium Tablets Sales Value Share by Application (2021-2032)
6 Sacubitril Valsartan Sodium Tablets Regional Sales and Value Analysis
  1. 6.1 Global Sacubitril Valsartan Sodium Tablets Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Sacubitril Valsartan Sodium Tablets Sales by Region (2021-2032)
  3. 6.2.1 Global Sacubitril Valsartan Sodium Tablets Sales by Region: 2021-2026
  4. 6.2.2 Global Sacubitril Valsartan Sodium Tablets Sales by Region (2027-2032)
  5. 6.3 Global Sacubitril Valsartan Sodium Tablets Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Sacubitril Valsartan Sodium Tablets Sales Value by Region (2021-2032)
  7. 6.4.1 Global Sacubitril Valsartan Sodium Tablets Sales Value by Region: 2021-2026
  8. 6.4.2 Global Sacubitril Valsartan Sodium Tablets Sales Value by Region (2027-2032)
  9. 6.5 Global Sacubitril Valsartan Sodium Tablets Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Sacubitril Valsartan Sodium Tablets Sales Value (2021-2032)
  12. 6.6.2 North America Sacubitril Valsartan Sodium Tablets Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Sacubitril Valsartan Sodium Tablets Sales Value (2021-2032)
  15. 6.7.2 Europe Sacubitril Valsartan Sodium Tablets Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Sacubitril Valsartan Sodium Tablets Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Sacubitril Valsartan Sodium Tablets Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Sacubitril Valsartan Sodium Tablets Sales Value (2021-2032)
  21. 6.9.2 South America Sacubitril Valsartan Sodium Tablets Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Sacubitril Valsartan Sodium Tablets Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Sacubitril Valsartan Sodium Tablets Sales Value Share by Country, 2025 VS 2032
7 Sacubitril Valsartan Sodium Tablets Country-level Sales and Value Analysis
  1. 7.1 Global Sacubitril Valsartan Sodium Tablets Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Sacubitril Valsartan Sodium Tablets Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Sacubitril Valsartan Sodium Tablets Sales by Country (2021-2032)
  4. 7.3.1 Global Sacubitril Valsartan Sodium Tablets Sales by Country (2021-2026)
  5. 7.3.2 Global Sacubitril Valsartan Sodium Tablets Sales by Country (2027-2032)
  6. 7.4 Global Sacubitril Valsartan Sodium Tablets Sales Value by Country (2021-2032)
  7. 7.4.1 Global Sacubitril Valsartan Sodium Tablets Sales Value by Country (2021-2026)
  8. 7.4.2 Global Sacubitril Valsartan Sodium Tablets Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Sacubitril Valsartan Sodium Tablets Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Sacubitril Valsartan Sodium Tablets Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Sacubitril Valsartan Sodium Tablets Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Sacubitril Valsartan Sodium Tablets Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Sacubitril Valsartan Sodium Tablets Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Sacubitril Valsartan Sodium Tablets Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Sacubitril Valsartan Sodium Tablets Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Sacubitril Valsartan Sodium Tablets Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Sacubitril Valsartan Sodium Tablets Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Sacubitril Valsartan Sodium Tablets Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Sacubitril Valsartan Sodium Tablets Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Sacubitril Valsartan Sodium Tablets Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Sacubitril Valsartan Sodium Tablets Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Sacubitril Valsartan Sodium Tablets Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Sacubitril Valsartan Sodium Tablets Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Sacubitril Valsartan Sodium Tablets Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Sacubitril Valsartan Sodium Tablets Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Sacubitril Valsartan Sodium Tablets Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Sacubitril Valsartan Sodium Tablets Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Sacubitril Valsartan Sodium Tablets Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Sacubitril Valsartan Sodium Tablets Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Sacubitril Valsartan Sodium Tablets Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Sacubitril Valsartan Sodium Tablets Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Sacubitril Valsartan Sodium Tablets Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Sacubitril Valsartan Sodium Tablets Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Sacubitril Valsartan Sodium Tablets Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Sacubitril Valsartan Sodium Tablets Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Sacubitril Valsartan Sodium Tablets Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Sacubitril Valsartan Sodium Tablets Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Sacubitril Valsartan Sodium Tablets Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Sacubitril Valsartan Sodium Tablets Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Sacubitril Valsartan Sodium Tablets Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Sacubitril Valsartan Sodium Tablets Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Sacubitril Valsartan Sodium Tablets Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Sacubitril Valsartan Sodium Tablets Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Sacubitril Valsartan Sodium Tablets Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Sacubitril Valsartan Sodium Tablets Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Sacubitril Valsartan Sodium Tablets Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Sacubitril Valsartan Sodium Tablets Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Sacubitril Valsartan Sodium Tablets Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Sacubitril Valsartan Sodium Tablets Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Sacubitril Valsartan Sodium Tablets Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Sacubitril Valsartan Sodium Tablets Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Sacubitril Valsartan Sodium Tablets Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Sacubitril Valsartan Sodium Tablets Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Sacubitril Valsartan Sodium Tablets Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Sacubitril Valsartan Sodium Tablets Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Sacubitril Valsartan Sodium Tablets Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Sacubitril Valsartan Sodium Tablets Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Sacubitril Valsartan Sodium Tablets Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Sacubitril Valsartan Sodium Tablets Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Sacubitril Valsartan Sodium Tablets Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Sacubitril Valsartan Sodium Tablets Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Sacubitril Valsartan Sodium Tablets Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Sacubitril Valsartan Sodium Tablets Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Sacubitril Valsartan Sodium Tablets Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Sacubitril Valsartan Sodium Tablets Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Sacubitril Valsartan Sodium Tablets Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Sacubitril Valsartan Sodium Tablets Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Sacubitril Valsartan Sodium Tablets Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Sacubitril Valsartan Sodium Tablets Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Sacubitril Valsartan Sodium Tablets Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Sacubitril Valsartan Sodium Tablets Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Sacubitril Valsartan Sodium Tablets Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Sacubitril Valsartan Sodium Tablets Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Sacubitril Valsartan Sodium Tablets Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Sacubitril Valsartan Sodium Tablets Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Sacubitril Valsartan Sodium Tablets Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Sacubitril Valsartan Sodium Tablets Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Sacubitril Valsartan Sodium Tablets Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Sacubitril Valsartan Sodium Tablets Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Sacubitril Valsartan Sodium Tablets Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Sacubitril Valsartan Sodium Tablets Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Sacubitril Valsartan Sodium Tablets Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Sacubitril Valsartan Sodium Tablets Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Sacubitril Valsartan Sodium Tablets Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Sacubitril Valsartan Sodium Tablets Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Sacubitril Valsartan Sodium Tablets Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Sacubitril Valsartan Sodium Tablets Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Sacubitril Valsartan Sodium Tablets Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Sacubitril Valsartan Sodium Tablets Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Sacubitril Valsartan Sodium Tablets Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Sacubitril Valsartan Sodium Tablets Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Sacubitril Valsartan Sodium Tablets Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Addii Biotech
  2. 8.1.1 Addii Biotech Company Information
  3. 8.1.2 Addii Biotech Business Overview
  4. 8.1.3 Addii Biotech Sacubitril Valsartan Sodium Tablets Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Addii Biotech Sacubitril Valsartan Sodium Tablets Product Portfolio
  6. 8.1.5 Addii Biotech Recent Developments
  7. 8.2 Arlak Corazon
  8. 8.2.1 Arlak Corazon Company Information
  9. 8.2.2 Arlak Corazon Business Overview
  10. 8.2.3 Arlak Corazon Sacubitril Valsartan Sodium Tablets Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Arlak Corazon Sacubitril Valsartan Sodium Tablets Product Portfolio
  12. 8.2.5 Arlak Corazon Recent Developments
  13. 8.3 Cipla
  14. 8.3.1 Cipla Company Information
  15. 8.3.2 Cipla Business Overview
  16. 8.3.3 Cipla Sacubitril Valsartan Sodium Tablets Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Cipla Sacubitril Valsartan Sodium Tablets Product Portfolio
  18. 8.3.5 Cipla Recent Developments
  19. 8.4 Farmanova pharma
  20. 8.4.1 Farmanova pharma Company Information
  21. 8.4.2 Farmanova pharma Business Overview
  22. 8.4.3 Farmanova pharma Sacubitril Valsartan Sodium Tablets Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Farmanova pharma Sacubitril Valsartan Sodium Tablets Product Portfolio
  24. 8.4.5 Farmanova pharma Recent Developments
  25. 8.5 General Pharmaceuticals
  26. 8.5.1 General Pharmaceuticals Company Information
  27. 8.5.2 General Pharmaceuticals Business Overview
  28. 8.5.3 General Pharmaceuticals Sacubitril Valsartan Sodium Tablets Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 General Pharmaceuticals Sacubitril Valsartan Sodium Tablets Product Portfolio
  30. 8.5.5 General Pharmaceuticals Recent Developments
  31. 8.6 MSN
  32. 8.6.1 MSN Company Information
  33. 8.6.2 MSN Business Overview
  34. 8.6.3 MSN Sacubitril Valsartan Sodium Tablets Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 MSN Sacubitril Valsartan Sodium Tablets Product Portfolio
  36. 8.6.5 MSN Recent Developments
  37. 8.7 Novartis
  38. 8.7.1 Novartis Company Information
  39. 8.7.2 Novartis Business Overview
  40. 8.7.3 Novartis Sacubitril Valsartan Sodium Tablets Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Novartis Sacubitril Valsartan Sodium Tablets Product Portfolio
  42. 8.7.5 Novartis Recent Developments
  43. 8.8 Sanof
  44. 8.8.1 Sanof Company Information
  45. 8.8.2 Sanof Business Overview
  46. 8.8.3 Sanof Sacubitril Valsartan Sodium Tablets Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Sanof Sacubitril Valsartan Sodium Tablets Product Portfolio
  48. 8.8.5 Sanof Recent Developments
  49. 8.9 Changzhou Pharmaceutical Factory
  50. 8.9.1 Changzhou Pharmaceutical Factory Company Information
  51. 8.9.2 Changzhou Pharmaceutical Factory Business Overview
  52. 8.9.3 Changzhou Pharmaceutical Factory Sacubitril Valsartan Sodium Tablets Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Changzhou Pharmaceutical Factory Sacubitril Valsartan Sodium Tablets Product Portfolio
  54. 8.9.5 Changzhou Pharmaceutical Factory Recent Developments
  55. 8.10 Chengdu Brilliant Pharmaceutical
  56. 8.10.1 Chengdu Brilliant Pharmaceutical Company Information
  57. 8.10.2 Chengdu Brilliant Pharmaceutical Business Overview
  58. 8.10.3 Chengdu Brilliant Pharmaceutical Sacubitril Valsartan Sodium Tablets Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Chengdu Brilliant Pharmaceutical Sacubitril Valsartan Sodium Tablets Product Portfolio
  60. 8.10.5 Chengdu Brilliant Pharmaceutical Recent Developments
  61. 8.11 TC Pharmaceuticals (Jiangsu)
  62. 8.11.1 TC Pharmaceuticals (Jiangsu) Company Information
  63. 8.11.2 TC Pharmaceuticals (Jiangsu) Business Overview
  64. 8.11.3 TC Pharmaceuticals (Jiangsu) Sacubitril Valsartan Sodium Tablets Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 TC Pharmaceuticals (Jiangsu) Sacubitril Valsartan Sodium Tablets Product Portfolio
  66. 8.11.5 TC Pharmaceuticals (Jiangsu) Recent Developments
  67. 8.12 Sino Therapeutics
  68. 8.12.1 Sino Therapeutics Company Information
  69. 8.12.2 Sino Therapeutics Business Overview
  70. 8.12.3 Sino Therapeutics Sacubitril Valsartan Sodium Tablets Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 Sino Therapeutics Sacubitril Valsartan Sodium Tablets Product Portfolio
  72. 8.12.5 Sino Therapeutics Recent Developments
  73. 8.13 Kelun Pharmaceutical
  74. 8.13.1 Kelun Pharmaceutical Company Information
  75. 8.13.2 Kelun Pharmaceutical Business Overview
  76. 8.13.3 Kelun Pharmaceutical Sacubitril Valsartan Sodium Tablets Sales, Value and Gross Margin (2021-2026)
  77. 8.13.4 Kelun Pharmaceutical Sacubitril Valsartan Sodium Tablets Product Portfolio
  78. 8.13.5 Kelun Pharmaceutical Recent Developments
  79. 8.14 Qilu Pharmaceutical
  80. 8.14.1 Qilu Pharmaceutical Company Information
  81. 8.14.2 Qilu Pharmaceutical Business Overview
  82. 8.14.3 Qilu Pharmaceutical Sacubitril Valsartan Sodium Tablets Sales, Value and Gross Margin (2021-2026)
  83. 8.14.4 Qilu Pharmaceutical Sacubitril Valsartan Sodium Tablets Product Portfolio
  84. 8.14.5 Qilu Pharmaceutical Recent Developments
  85. 8.15 Shenzhen Salubris Pharmaceuticals
  86. 8.15.1 Shenzhen Salubris Pharmaceuticals Company Information
  87. 8.15.2 Shenzhen Salubris Pharmaceuticals Business Overview
  88. 8.15.3 Shenzhen Salubris Pharmaceuticals Sacubitril Valsartan Sodium Tablets Sales, Value and Gross Margin (2021-2026)
  89. 8.15.4 Shenzhen Salubris Pharmaceuticals Sacubitril Valsartan Sodium Tablets Product Portfolio
  90. 8.15.5 Shenzhen Salubris Pharmaceuticals Recent Developments
  91. 8.16 CSPC Ouyi Pharmaceutical
  92. 8.16.1 CSPC Ouyi Pharmaceutical Company Information
  93. 8.16.2 CSPC Ouyi Pharmaceutical Business Overview
  94. 8.16.3 CSPC Ouyi Pharmaceutical Sacubitril Valsartan Sodium Tablets Sales, Value and Gross Margin (2021-2026)
  95. 8.16.4 CSPC Ouyi Pharmaceutical Sacubitril Valsartan Sodium Tablets Product Portfolio
  96. 8.16.5 CSPC Ouyi Pharmaceutical Recent Developments
  97. 8.17 Sihuan Pharmaceutical
  98. 8.17.1 Sihuan Pharmaceutical Company Information
  99. 8.17.2 Sihuan Pharmaceutical Business Overview
  100. 8.17.3 Sihuan Pharmaceutical Sacubitril Valsartan Sodium Tablets Sales, Value and Gross Margin (2021-2026)
  101. 8.17.4 Sihuan Pharmaceutical Sacubitril Valsartan Sodium Tablets Product Portfolio
  102. 8.17.5 Sihuan Pharmaceutical Recent Developments
  103. 8.18 Zhejiang AngLiKang Pharmaceutical
  104. 8.18.1 Zhejiang AngLiKang Pharmaceutical Company Information
  105. 8.18.2 Zhejiang AngLiKang Pharmaceutical Business Overview
  106. 8.18.3 Zhejiang AngLiKang Pharmaceutical Sacubitril Valsartan Sodium Tablets Sales, Value and Gross Margin (2021-2026)
  107. 8.18.4 Zhejiang AngLiKang Pharmaceutical Sacubitril Valsartan Sodium Tablets Product Portfolio
  108. 8.18.5 Zhejiang AngLiKang Pharmaceutical Recent Developments
  109. 8.19 Zhejiang Nord Pharmaceutical
  110. 8.19.1 Zhejiang Nord Pharmaceutical Company Information
  111. 8.19.2 Zhejiang Nord Pharmaceutical Business Overview
  112. 8.19.3 Zhejiang Nord Pharmaceutical Sacubitril Valsartan Sodium Tablets Sales, Value and Gross Margin (2021-2026)
  113. 8.19.4 Zhejiang Nord Pharmaceutical Sacubitril Valsartan Sodium Tablets Product Portfolio
  114. 8.19.5 Zhejiang Nord Pharmaceutical Recent Developments
  115. 8.20 Chia Tai Tianqing Pharmaceutical
  116. 8.20.1 Chia Tai Tianqing Pharmaceutical Company Information
  117. 8.20.2 Chia Tai Tianqing Pharmaceutical Business Overview
  118. 8.20.3 Chia Tai Tianqing Pharmaceutical Sacubitril Valsartan Sodium Tablets Sales, Value and Gross Margin (2021-2026)
  119. 8.20.4 Chia Tai Tianqing Pharmaceutical Sacubitril Valsartan Sodium Tablets Product Portfolio
  120. 8.20.5 Chia Tai Tianqing Pharmaceutical Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Sacubitril Valsartan Sodium Tablets Value Chain Analysis
  2. 9.1.1 Sacubitril Valsartan Sodium Tablets Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Sacubitril Valsartan Sodium Tablets Sales Mode & Process
  6. 9.2 Sacubitril Valsartan Sodium Tablets Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Sacubitril Valsartan Sodium Tablets Distributors
  9. 9.2.3 Sacubitril Valsartan Sodium Tablets Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research